Smith & Nephew plc vs S&P500 ETF — how do they compare? Smith & Nephew plc trades at $30.45 (market cap $12.64B), while S&P500 ETF trades at $748.15. The key difference: Smith & Nephew plc pays a 2.57% dividend while S&P500 ETF pays none, and S&P500 ETF is trading nearer its 52-week high, Smith & Nephew plc nearer its low. Which is the better fit depends on your goals.
| SNN | SPY | |
|---|---|---|
Market Cap | $12.64B | — |
Sector | Health | — |
52-Week High | $38.70 | $759.55 |
52-Week Low | $28.73 | $621.75 |
Enterprise Value | $15.41B | — |
Dividend Yield | 2.57% | — |
Signals from Pluang's Aura AI — not financial advice
SNN trades at $30.21, down 1.24% today, with a bearish technical signal and mixed earnings history. Revenue grew to $5.81B in 2024 with net income of $412M, while valuation ratios like P/E of 21.25 and P/S of 2.15 suggest moderate pricing. Recent news highlights product launches in robotics and wound care, supporting growth initiatives.
Outlook is cautiously optimistic with strong cash flow and analyst buy ratings at 27%, but risks include earnings misses and rising debt. The stock offers potential from operational improvements, though investor sentiment remains divided amid competitive pressures.
SPY, the SPDR S&P 500 ETF, trades at $748.32, up 0.7% with a bearish technical bias as it faces resistance near $747-$754. The ETF reflects broad market dynamics, with recent news highlighting AI-driven industrial growth and concerns over S&P 500 valuations nearing historical highs. A dividend of $1.90 is scheduled for July 2026, providing income amid volatility.
Outlook remains cautious due to technical resistance and valuation concerns, but long-term exposure to large-cap US equities offers diversification. Risks include market overvaluation and economic headwinds, while institutional holdings support stability. Investors should weigh technical signals against fundamental market breadth.
Trailing returns across standard periods
Latest headlines on both assets
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on SPY →